|
|
- 2017
Predictive Value of Serum Infliximab Levels at Induction Phase in Rheumatoid Arthritis PatientsDOI: 10.2174/1874312901711010075 Keywords: Infliximab therapy, Rheumatoid Arthritis, Induction phase, Levels clearance, Loss of efficacy, Early immunogenicity Abstract: The Infliximab, has proven effective in treating rheumatoid arthritis (RA). A good clinical response is usually associated with high serum drug levels. Development of antibodies toward Infliximab (ATI) can increase drug clearance, leading to treatment failure
|
